A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects
PHASE1CompletedINTERVENTIONAL
Enrollment
56
Participants
Timeline
Start Date
January 31, 2014
Primary Completion Date
March 31, 2014
Study Completion Date
April 30, 2014
Conditions
Drug-drug Interaction
Interventions
DRUG
AVP-786
DRUG
Paroxetine
DRUG
Duloxetine
Trial Locations (1)
3004
Nucleus Network, Melbourne
All Listed Sponsors
lead
Otsuka Pharmaceutical Development & Commercialization, Inc.
INDUSTRY
NCT02174822 - A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects | Biotech Hunter | Biotech Hunter